Skip to main content
Focused investors/ValueAct Capital

ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter
+11.81%
1-year
-6.13%
3-year
+68.78%
5-year
+54.42%
3-year vs S&P 500
-4.46%
5-year vs S&P 500
-19.26%
5-year top 5
+37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 10 of 14 rows. Rows without a quote are marked unavailable.

1MSFTMICROSOFT CORP19.36%Reduce -31.8%38,624,678$2.22B$57.60No quote
2BHIBAKER HUGHES INC13.13%Reduce -23.1%29,886,200$1.51BNo quoteNo quote
3MSMORGAN STANLEY11.69%Add +10.3%41,900,000$1.34B$32.06No quote
4FOXTWENTY-FIRST CENTURY FOX INC10.84%Add +6.3%50,326,334$1.25B$24.74No quote
5WTWWILLIS TOWERS WATSON PUB LTD9.37%-8,108,015$1.08B$132.77No quote
6BFHALLIANCE DATA SYSTEMS CORP9.33%Add +52.1%5,000,000$1.07B$214.53No quote
7CBRECBRE GROUP INC8.43%Add +5.1%34,620,054$968.67M$27.98No quote
8ALSNALLISON TRANSMISSION HLDGS I4.77%-19,125,204$548.51M$28.68No quote
9AWIARMSTRONG WORLD INDS INC NEW3.31%-9,200,000$380.14M$41.32No quote
10VRXVALEANT PHARMACEUTICALS INTE3.20%-14,994,261$368.11MNo quoteNo quote
11STXSEAGATE TECHNOLOGY PLC3.20%Add +218.0%9,539,490$367.75M$38.55No quote
12TRNTRINITY INDS INC2.61%Add +107.0%12,421,000$300.34M$24.18No quote
13AFIIQARMSTRONG FLOORING INC0.76%-4,600,000$86.85MNo quoteNo quote
14MSCIMSCI INC-Sold0$0No quoteNo quote